U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:21:25 UTC 2021
Edited
by admin
on Sat Jun 26 18:21:25 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
8GZG754X6M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GEMTUZUMAB OZOGAMICIN
EMA EPAR   INN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
GEMTUZUMAB OZOGAMICIN [USAN]
Common Name English
GEMTUZUMAB OZOGAMICIN [MI]
Common Name English
CMC-676
Code English
CMA-676
Code English
GEMTUZUMAB OZOGAMICIN [VANDF]
Common Name English
MYLOTARG
Brand Name English
GEMTUZUMAB OZOGAMICIN RECOMBINANT
Common Name English
GEMTUZUMAB OZOGAMICIN [EMA EPAR]
Common Name English
GEMTUZUMAB OZOGAMICIN [ORANGE BOOK]
Common Name English
GEMTUZUMAB OZOGAMICIN [WHO-DD]
Common Name English
WAY-CMA-676
Code English
GEMTUZUMAB OZOGAMICIN [MART.]
Common Name English
GEMTUZUMAB OZOGAMICIN (GENETICAL RECOMBINATION)[JAN]
JAN  
Common Name English
GEMTUZUMAB OZOGAMICIN [INN]
Common Name English
GEMTUZUMAB OZOGAMICIN [PURPLE BOOK, CDER]
Common Name English
CDP-771
Code English
L01XC05
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/00/005
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
NDF-RT N0000175571
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
NCI_THESAURUS C129823
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
WHO-ATC L01XC05
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
EMA ASSESSMENT REPORTS MYLOTARG (REFUSED: LEUKEMIA, MYELOID, ACUTE)
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
NCI_THESAURUS C2333
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
LIVERTOX 454
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
FDA ORPHAN DRUG 127899
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
Code System Code Type Description
MERCK INDEX
M5694
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY Merck Index
ChEMBL
CHEMBL1201506
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
RXCUI
1294580
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY RxNorm
CAS
220578-59-6
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
WIKIPEDIA
Gemtuzumab ozogamicin
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
LACTMED
Gemtuzumab Ozogamicin
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
EVMPD
SUB20794
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
IUPHAR
6775
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
NCI_THESAURUS
C1806
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
FDA UNII
8GZG754X6M
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
DRUG CENTRAL
4980
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
DRUG BANK
DB00056
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
INN
10315
Created by admin on Sat Jun 26 18:21:25 UTC 2021 , Edited by admin on Sat Jun 26 18:21:25 UTC 2021
PRIMARY
From To
1_22 1_96
1_143 1_199
1_257 1_317
1_363 1_421
2_22 2_96
2_143 2_199
2_257 2_317
2_363 2_421
1_130 3_218
2_130 4_218
1_222 2_222
1_225 2_225
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_293
N 2_293
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL